Pixilab
Home › Companies › SEC Form D - Biotechnology › Cellics Therapeutics, Inc.

Cellics Therapeutics, Inc.

SEC Form D private-offering issuer in Biotechnology

Operating in sec form d - biotechnology based in SAN DIEGO, CALIFORNIA, Cellics Therapeutics, Inc. was founded in 2014.

Profile

Private US issuer recorded in the SEC Form D structured dataset for 2016Q1. Industry: Biotechnology. Revenue range: Decline to Disclose. Offering amount: 6000050.

Cellics Therapeutics, Inc. is positioned in sec form d - biotechnology, a segment that rewards a clear, focused offering.

The company is recorded as being based in SAN DIEGO, CALIFORNIA.

Directory data places it at the Regulation D stage.

Recorded headcount: 11-50 employees.

Public records show total funding of about $6M.

SectorSEC Form D - Biotechnology
HeadquartersSAN DIEGO, CALIFORNIA
CountryUnited States
Founded2014
Employees11-50
StageRegulation D
Total funding$6,000,050

Website: cellics.com

Browse related

More SEC Form D - Biotechnology companies Companies in United States Companies founded in 2014
Emails and contact routes are reserved for registered members.
Create a free account